newsfilter
← Latest News
GlobeNewswire·

Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference

SAN CARLOS, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (NASDAQ:PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial